Browse All

Current Filters

CLEAR FILTER x

TITLE

Author Institution:

Safety and Efficacy of Riliprubart, an Activated C1s-complement Inhibitor in CIDP: 76-week Phase Two Trial Results

Author:Querol, Luis   Lewis, Richard A.   Hartung, Hans-Peter   van Doorn, Pieter A.   Lin, Jie   Dionne, Annie   Attarian, Shahram   Wallstroem, Erik   Auwarter, Kristen   Lu, Yi   Alonso-Alonso, Miguel   Atassi, Nazem   Hughes, Richard A. C.   

Session Name:S2: Updates on Motor Neuron and Peripheral Nerve Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S2.008  

Author Institution:Neuromuscular Diseases Unit, Department of Neurology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain  Centro para la Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain, Spain  Department of Neurology, Cedars Sinai Medical Center, Los Angeles, CA, USA, CA  Department of Neurology, Faculty of Medicine, Heinrich-Heine-University, Düsseldorf, Germany  Brain and Mind Center, University of Sydney, Sydney, NSW, Australia  Department of Neurology, Medical University of Vienna, Vienna, Austria  Department of Neurology, Palacky University Olomouc, Olomouc, The Czech Republic, Dusseldorf, Germany  Erasmus MC, University Medical Center, Rotterdam, The Netherlands, Netherlands  Department of Neurology and Rare Disease Center, Huashan Hospital, Fudan University, Shanghai, China, Shanghai, China, People's Republic of  CHU de Quebec Universite Laval, Quebec, Canada, QC, Canada  Neuromuscular Disease and ALS Reference Center, Timone University Hospital, Aix-Marseille University, CHU Timone, Marseille Cedex 05, France, France  Sanofi R&D, Neurology Development, Cambridge, MA, USA, Cambridge, MA  Sanofi, USA, MA  Sanofi R&D, Biostatistics and Programming, Cambridge, MA, USA, CA  Sanofi R&D, Neurology Development, Cambridge, MA, USA, MA  UCL Queen Square Institute of Neurology, University College London, London, UK, United Kingdom  

Fenfluramine in CDKL5 Deficiency Disorder: Primary Efficacy and Safety Results from a Phase 3, Randomized, Double-blind, Placebo-controlled Study

Author:Moseley, Brian   Specchio, Nicola   Marsh, Eric   Devinsky, Orrin   Aledo-Serrano, Ángel   Immacolata Battaglia, Domenica   Rajaraman, Rajsekar   Keough, Karen   Honda, Ryoko   Guerrini, Renzo   Melikishivili, Gia   Amin, Sam   Jaksha, Amanda   St. Wecker, Peter   Kilgallen, Brian   Dickson, Najla   Sullivan, Joseph   

Session Name:S5: Clinical Epilepsy  

Topic:Epilepsy/Clinical Neurophysiology (EEG)  

Program Number:S5.010  

Author Institution:UCB, Morrisville, NC  Bambino Gesù Children’s Hospital, IRCCS, Member of European Reference Network (ERN) EpiCARE  University Hospitals KU, Rome, Italy  Children's Hospital of Philadlephia  Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA  NYU Epilepsy Center, New York, NY  Neuroscience Institute, Vithas Madrid La Milagrosa University Hospital, Madrid, Spain  Fondazione Policlinico Universitario Agostino Gemelli, IRCCS  Università Cattolica del Sacro Cuore, Rome, Italy  David Geffen School of Medicine  UCLA Mattel Children’s Hospital, Los Angeles, CA  Child Neurology and Consultants of Austin, Austin, TX  Nagasaki Medical Center, Omura, Nagasaki, Japan  Meyer Children's Hospital IRCCS, Member of the ERN EpiCARE  University of Florence, Florence, Italy  MediClubGeorgia Medical Center, Tbilisi, Georgia  University Hospitals Bristol and Weston, Bristol, United Kingdom  Patient caregiver, Denver, CO  UCB, Emeryville, CA  Weill Institute for Neurosciences and Benioff Children’s Hospital, University of California San Francisco, San Francisco, CA  

Maintenance Immunotherapy in MOGAD: Early Steroid Benefit, Dose Thresholds, and Disability Risk

Author:Trewin, Benjamin   Forcadela, Mirasol   Rocchi, Chiara   Qiu, Jessica   Chu, Melissa   Jeyakumar, Niroshan   Dela Cruz, Fionna   Andersen, Jane   Siriratnam, Pakeeran   McLean, Antonia   Yagnik, Deepti   Lizak, Nathaniel   Chan, Fiona   Hardy, Todd   Van Der Walt, Anneke   Lechner-Scott, Jeannette   Butzkueven, Helmut   Broadley, Simon   Barnett, Michael   Reddel, Stephen   Brilot, Fabienne   Dale, Russell   Huda, Saif   Kalincik, Tomas   Ramanathan, Sudarshini   

Session Name:S6: Autoimmune Neurology: NMOSD and MOGAD  

Topic:Autoimmune Neurology  

Program Number:S6.001  

Author Institution:University of Sydney, Sydney, Australia  NHS, Liverpool, United Kingdom  Westmead Hospital, Sydney, Australia  The Royal Melbourne Hospital, Melbourne, Australia  Monash University, Keysbourgh, Australia  Fiona Stanley Hospital, Murdoch, Australia  Alfred Health, Melbourne, Australia  HNEAH, Newcastle, Australia  Griffith University School of Medicine, Nathan, Australia  The Children's Hospital At Westmead, Westmead, Australia  University of Melbourne, Melbourne, Australia  

Conformational PLP-1 Antibodies as a Prognostic Biomarker in MOGAD

Author:Greco, Giacomo   Masciocchi, Stefano   Businaro, Pietro   Zuliani, Federica   Vacca, Margherita   Morandi, Chiara   Rigoni, Eleonora   Bruno, Giorgia   Carta, Sara   Risi, Mario   Lo Bianco, Manuela   Covelli, Antonio   Cellante, Giulia   Sperandei, Silvia   Santagostino Barbone, Alessandro   Foiadelli, Thomas   Bisecco, Alvino   Curti, Erica   Turco, Emanuela Claudia   Gallo, Antonio   Rocchi, Chiara   Huda, Saif   Mancardi, Margherita   Di Filippo, Massimiliano   Fabris, Martina   Vogrig, Alberto   Vidale, Simone   Ruggieri, Martino   Varone, Antonio   Mariotto, Sara   Arrambide, Georgina   Cobo Calvo, Alvaro   Marignier, Romain   Colombo, Elena   Gastaldi, Matteo   

Session Name:S6: Autoimmune Neurology: NMOSD and MOGAD  

Topic:Autoimmune Neurology  

Program Number:S6.010  

Author Institution:IRCCS Mondino Foundation, Pavia, Italy  Santobono-Pausilipon Children’s Hospital, Naples, Italy  University of Verona, Verona, Italy  University of Catania, Catania, Italy  ASST SetteLaghi, Ospedale di Circolo/Fondazione Macchi, Varese, Italy  University of Udine, Udine, Italy  University of Perugia, Perugia, Italy  University of Genova, Genova, Italy  University of Pavia, Pavia, Italy  University of Campania "Luigi Vanvitelli", Naples, Italy  Parma University Hospital, Parma, Italy  Walton Centre NHS Foundation Trust, Liverpool, United Kingdom  Cemcat, Vall d´Hebron University Hospital, BARCELONA, Spain  Lyon University Hospital, Lyon, France  

Evaluating Functional Changes and Outcome Measure Responsiveness in Limb Girdle Muscular Dystrophy: A 12-month Analysis of the 10-meter Run Time, NSAD, and PUL

Author:Patel, Roshni   Alfano, Lindsay   Mozaffar, Tahseen   Mathews, Katherine   Weihl, Conrad   Statland, Jeffrey   Leung, Doris   Kang, Peter   Ammous, Zineb   Dixon, Stacy   Diaz-Manera, Jordi   Subramony, S   Wicklund, Matthew   Johnson, Nicholas   Kiefer, Michael   

Session Name:S7: Updates on Muscle Disorders  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S7.002  

Author Institution:Virginia Commonwealth University School of Medicine, Richmond, VA  Nationwide Children'S Hospital, Columbus, OH  University of California Irvine, Orange, CA  University of Iowa - Dept of Pediatrics, Iowa City, IA  Washington University in St. Louis, St. Louis, MO  University of Kansas Medical Center, Kansas City, KS  Kennedy Krieger Institute, Baltimore, MD  University of Minnesota Medical School, Minneapolis, MN  Indiana Community Health Clinic, Shipshewana, IN  University of Colorado, Aurora, CO  Newcastle University, Newcastle, United Kingdom  University of Florida, Gainesville, FL  UT Health San Antonio, San Antonio, TX  Virginia Commonwealth University, Richmond, VA